Effect of pentoxifylline on differentiation and maturation of human monocyte-derived dendritic cells in vitro

International Immunopharmacology

Volumn 7, Issue 2, 2007, Pages 167-174

  Vukanić, Zorica Stojić ^a   Čolić, Miodrag ^b   Dimitrijevic M ^a  

^a School of Pharmacy   (Yugoslavia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Alloreactivity; Culture phenotype; Cytokine production; Human dendritic cells; Pentoxifylline

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; DEXTRAN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; MOLECULAR MARKER; PENTOXIFYLLINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ALLOIMMUNITY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; NEUROBLAST; PRIORITY JOURNAL; STIMULATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; IMMUNOLOGIC FACTORS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MONOCYTES; PENTOXIFYLLINE; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES;

EID: 33846012884     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.09.005     Document Type: Article

References (43)

1. Smith R.V., Waller E.S., Doluisio J.T., Bauza M.T., Puri S.K., Ho I., et al. Pharmacokinetics of orally administered pentoxifylline in humans. J Pharm Sci 75 (1986) 47-52
2. Funk J.O., Ernst M., Schonharting M.M., and Zabel P. Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A. Int J Immunopharmacol 17 (1995) 1007-1016
3. Marcinkiewicz J., Grabowska A., Lauterbach R., and Bobek M. Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages. Immunopharmacology 49 (2000) 335-343
4. van Furth A.M., Verhard-Seijmonsbergen E.M., van Furth R., and Langermans J.A. Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta, IL-10 by human leucocytes. Immunology 91 (1997) 193-196
5. Moller D.R., Wysocka M., Greenlee B.M., Ma X., Wahl L., Trinchieri G., et al. Inhibition of human interleukin-12 production by pentoxifylline. Immunology 91 (1997) 197-203
6. Anaya J.M., and Espinoza L.R. Phosphodiesterase inhibitor pentoxifylline: an anti-inflammatory/immunomodulatory drug potentially useful in some rheumatic diseases. J Rheumatol 22 (1995) 595-599
7. Nagy Z., Sipka R., Ocsovszki I., Balogh A., and Mandi Y. Suppressive effect of pentoxifylline on natural killer cell activity; experimental and clinical studies. Naunyn-Schmiedeberg's Arch Pharmacol 359 (1999) 228-234
8. Rott O., Cash E., and Fleischer B. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in lewis rats. Eur J Immunol 23 (1993) 1745-1751
9. Rieckmann P., Weber F., Gunther A., Martin S., Bitsch A., Broocks A., et al. Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuroimmunol 64 (1996) 193-200
10. Maksymowych W.P., Avina-Zubieta A., Luong M.H., and Russell A.S. An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis. J Rheumatol 22 (1995) 625-629
11. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
12. Banchereau J., and Steinman R.M. Dendritic cells and control of immunity. Nature 329 (1998) 245-252
13. Cella M., Scheidegger D., Palmer-Kersten K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184 (1996) 747-752
14. Rissoan M.C., Soumelis V., Kadowaki N., Groiard G., Briere F., de Waal Malefyt R., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
15. Pulendran C., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 96 (1999) 1036-1041
16. Gonzalez-Amaro R., Portales-Perez D., Baranda L., Redondo J.M., Martinez-Martinez S., Yanez-Mo M., et al. Pentoxifylline inhibits adhesion and activation of human T lymphocytes. J Immunol 161 (1998) 65-72
17. Stojić-Vukanić Z., Dimitrijević M., Čolić M., Popović P., and Jandrić D. Modulation of human peripheral blood mononuclear cell activation by the combination of leflunomide and pentoxifylline. Transpl Proc 33 (2001) 2137-2138
18. Čolić M., Jandrić D., Stojić-Vukanić Z., Antić-Stanković J., Popović P., Vasilijić S., et al. Differentiation of human dendritic cells from monocytes in vitro using granulocyte-macrophage colony stimulating factor and low concentration of interleukin-4. Vojnosanit Pregl 60 (2003) 531-538
19. Čolić M., Mojsilović S., Pavlović B., Vuèiæević D., Majstorović I., Bufan B., et al. Comparison of two different protocols for the induction of maturation of human dendritic cells in vitro. Vojnosanit Pregl 61 (2004) 471-478
20. Hay H., and Cohen J. Studies on the specificity of the L929 cell bioassay for the measurement of the tumor necrosis factor. J Clin Lab Immunol 29 (1989) 151-155
21. Abe M., and Thomson A.W. Influence of immunosuppressive drugs on dendritic cells. Transplant Immunol 11 (2003) 357-365
22. Hackstein H., and Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4 (2004) 24-35
23. Lokshin A.E., Kalinski P., Sassi R.R., Mailliard R.B., Muller-Berghaus J., Storkus W.J., et al. Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II. Int Immunol 14 (2002) 1027-1037
24. Caux C., Massacrier C., Vandervliet B., Dubois B., van Kooten C., Durand I., et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180 (1994) 1263-1272
25. Lechmann M., Berchtold S., Hauber J., and Steinkasserer A. CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol 23 (2002) 273-275
26. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Eugenio Leone B., et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162 (1999) 6473-6481
27. Woltman A.M., de Fijter J.W., Kamerling S.W., Paul L.C., Daha M.R., and van Kooten C. The effects of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 30 (2000) 1807-1812
28. Čolić M., Stojić-Vukanić Z., Pavlović B., Jandrić D., and Stefanoska I. Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Clin Exp Immunol 134 (2003) 63-69
29. Woltman A.M., De Fijter J.W., Kamerling S.W., van der Kooij S.W., Paul L.C., Daha M.R., et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells, but not in monocytes and macrophages. Blood 98 (2001) 174-180
30. Matasic R., Dietz A.B., and Vuk-Pavlovic S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology 101 (2000) 53-60
31. 3 inhibits differentiation, maturation, activation, and survival od dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164 (2000) 2405-2411
32. 3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164 (2000) 4443-4451
33. Verhasselt V., Vanden Berghe W., Vanderahyde N., Willems F., Haegeman G., and Goldman M. N-acetyl-l-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-κB inhibition. J Immunol 162 (1999) 2569-2574
34. Ammon C., Mondal K., Andreesen R., and Krause S.W. Differential expression of the transcription factor NF-κB during human mononuclear phagocyte differentiation to macrophages and dendritic cells. Biochem Biophys Res Commun 268 (2000) 99-105
35. Neumann M., Fries H.W., Scheicher C., Keikavoussi P., Kolb-Maurer A., Brocker E.B., et al. Differential expression of Rel/NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 95 (2000) 277-285
36. Koski G.K., Schwartz G.N., Weng D.E., Gress R.E., Engels F.H.C., Tsokos M., et al. Calcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood 94 (1999) 1359-1371
37. Faries M.B., Bedrosian I., Xu S., Koski G., Roros J.G., Moise M.A., et al. Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development. Blood 98 (2001) 2489-2497
38. Jacob C.O., Fronek Z., Lewis G.D., Koo M., Hansen J.A., and McDevitt H.O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 87 (1990) 1233-1237
39. Jimenez J.L., Punzon C., Navarro J., Munoz-Fernandez A.M., and Fresno M. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-κB and nuclear factor of activated T cells activation. J Pharmacol Exp Ther 299 (2001) 753-759
40. Sampaio E.P., Moraes M.O., Nery J.A.C., Santos A.R., Matos H.C., and Sarno E.N. Pentoxifylline decreases in vivo and in vitro tumor necrosis factor-alpha (TNF-α) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin Exp Immunol 111 (1998) 300-308
41. Tajima K., Amakawa R., Ito T., Miyaji M., Takebayashi M., and Fukuhara S. Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets. Immunology 108 (2003) 321-328
42. Williams L.M., Ricchetti G., Sarma U., Smallie T., and Foxwell B.M.J. Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology 113 (2004) 281-292
43. Adorini L., Giarratana N., and Penna G. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16 (2004) 127-134